Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Quantitative autoradiographic mapping of focal herpes simplex virus encephalitis using a radiolabeled antiviral drug

Patent ·
OSTI ID:5860979
A method of mapping herpes simplex viral infection comprising administering a radiolabeled antiviral active 5-substituted 1-(2'-deoxy-2'-substituted-D-arabinofuranosyl) pyrimidine nucleoside to the infected subject, and scanning the area in which the infection is to be mapped for the radiolabel.
Assignee:
Sloan-Kettering for Cancer Research
Patent Number(s):
US 4489052
OSTI ID:
5860979
Country of Publication:
United States
Language:
English

Similar Records

Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug
Journal Article · Fri Sep 17 00:00:00 EDT 1982 · Science (Washington, D.C.); (United States) · OSTI ID:6529072
Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: autoradiographic assessment in an animal model
Journal Article · Fri Jun 01 00:00:00 EDT 1984 · Ann. Neurol.; (United States) · OSTI ID:6801418
Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model
Journal Article · Tue Sep 01 00:00:00 EDT 1987 · J. Am. Acad. Dermatol.; (United States) · OSTI ID:5717072

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
ENCEPHALITIS
HERPES SIMPLEX
INFECTIOUS DISEASES
ISOTOPE APPLICATIONS
LABELLED COMPOUNDS
MAPPING
NERVOUS SYSTEM DISEASES
RADIOPHARMACEUTICALS
SKIN DISEASES
TRACER TECHNIQUES
VIRAL DISEASES